Net survival of perinatally and postnatally HIV-infected children: A pooled analysis of individual data from sub-Saharan Africa

International Journal of Epidemiology

Volumn 40, Issue 2, 2011, Pages 385-396

  Marston, Milly ^a   Becquet, Renaud ^b,c   Zaba, Basia ^a   Moulton, Lawrence H ^d,e   Gray, Glenda ^f,g,h,i   Coovadia, Hoosen ^j   Essex, Max ^k,l   Ekouevi, Didier K ^b,c,m   Jackson, Debra ⁿ   Coutsoudis, Anna ^o   Kilewo, Charles ^p   Leroy, Valériane ^q,r   Wiktor, Stefan ^s,t   Nduati, Ruth ^u   Msellati, Philippe ^v,w,x   Dabis, François ^b,c   Newell, Marie Louise ^j,y   Ghys, Peter D ^z  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d ZVITAMBO trial   (Zimbabwe)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f Petra trial   (Tanzania)

^g Petra trial   (South Africa)

^h Petra trial   (Uganda)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^j UNIVERSITY OF KWAZULU NATAL   (South Africa)

^k Mashi trial   (Botswana)

^l Harvard AIDS Institute   (United States)

^m Ditrame Plus cohort   (Côte d’Ivoire)

ⁿ UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^o Vitamin A trial   (South Africa)

^p Mitra Plus cohort   (Tanzania)

^q ANRSa trial   (Côte d’Ivoire)

^r ANRSa trial   (Burkina Faso)

^s Retro Ci trial   (Côte d’Ivoire)

^t CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^u Universities of Nairobi Illinois and Manitoba (UNIM) Project   (Kenya)

^v ANRSb trial   (Côte d’Ivoire)

^w ANRSb trial   (Burkina Faso)

^x UNIVERSITÉ DE MONTPELLIER   (France)

^y UNIVERSITY COLLEGE LONDON   (United Kingdom)

^z UNAIDS   (Switzerland)

more..

Author keywords

HIV; Paediatric; Survival

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; ZIDOVUDINE;

BREASTFEEDING; CHILD HEALTH; DISEASE TREATMENT; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY; SURVIVAL;

AFRICA SOUTH OF THE SAHARA; ARTICLE; CAUSE OF DEATH; CHILDHOOD MORTALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; NEWBORN MORTALITY; PERINATAL DEATH; PERINATAL INFECTION; PERINATAL PERIOD; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURVIVAL;

SUB-SAHARAN AFRICA;

EID: 79953689588     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq255     Document Type: Article

References (25)

1. Marston M, Zaba B, Salomon JA, Brahmbhatt H, Bagenda D. Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr 2005;38:219-27.
2. Stover J, Walker N, Grassly NC, Marston M. Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the spectrum projection package. Sex Transm Infect 2006; 82(Suppl. 3):iii45-50.
3. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236-43.
4. Becquet R, Marston M, Dabis F, Zaba B, Newell ML, Ghys PD. Survival of Children HIV-Infected Perinatally or through Breastfeeding. A Pooled Analysis of Individual Data from Sub-Saharan Africa. The 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, USA, 2010.
5. Marston M, Todd J, Glynn JR, et al. Estimating 'net' HIV-related mortality and the importance of background mortality rates. Aids 2007;21(Suppl. 6):S65-71.
6. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107-16.
7. Dabis F, Elenga N, Meda N, et al. 18-Month mortality and perinatal exposure to zidovudine in West Africa. AIDS 2001;15:771-79.
8. Humphrey JH, Iliff PJ, Marinda ET, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006;193:860-71.
9. Jackson DJ, Chopra M, Doherty TM, et al. Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1. AIDS 2007;21:509-16.
10. Kilewo C, Karlsson K, Ngarina M, et al. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. J Acquir Immune Defic Syndr 2009;52:406-16.
11. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002;359: 1178-86.
12. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006;296:794-805.
13. Becquet R, Bequet L, Ekouevi DK, et al. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Cote d'Ivoire. PLoS Med 2007;4:e17.
14. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999;353:781-85.
15. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-tochild HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999;13:1517-24.
16. Mandelbrot L, Msellati P, Meda N, et al. 15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery. Sex Transm Infect 2002;78:267-70.
17. Nduati R, John G, Mbori Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000;283:1167-74.
18. Downs AM, Salamina G, Ancelle Park, RA. Incubation period of vertically acquired AIDS in Europe before widespread use of prophylactic therapies. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:297-304.
19. Todd J, Glynn JR, Marston M, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007; 21(Suppl. 6):S55-63.
20. CASCADE. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000;355:1131-37.
21. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Lancet 2000;355:451-55.
22. Demographic and Health Surveys. MEASURE DHS. 1984-present [updated Jan 10, 2009; cited 2009 Jan 10, 2009]; Available from: http://www.measuredhs.com.
23. Brahmbhatt H. (ed.). Maternal HIV and Child Survival in Rakai. Uganda: Demographic Impact of HIV, 2003. Durban.
24. Berhane R, Bagenda D, Marum L, et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics 1997;100:E7.
25. Stover J, Johnson P, Hallett T, Marston M, Becquet R, Timaeus IM. The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sexually Trans Infect 2010 (In Press).